Arguments for a two-dose yellow fever vaccination regimen in travellers

J Travel Med. 2019 Sep 2;26(6):taz004. doi: 10.1093/jtm/taz004.

Authors

Andreas Neumayr^{1

2}, Cornelia Stähelin³, Esther Kuenzli^{1

2}, Christoph Hatz^{1

2}

Affiliations

¹ Department of Medicine, Swiss Tropical and Public Health Institute, P.O. Box, Socinstrasse 57, Basel, Switzerland.
² University of Basel, Basel, Switzerland.
³ Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

PMID: 30657977
DOI: 10.1093/jtm/taz004

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Neutralizing
Humans
Travel
Vaccination
Yellow Fever*
Yellow fever virus / immunology*

Substances

Antibodies, Neutralizing